Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation
about
Approved Antiviral Drugs over the Past 50 YearsAged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women.Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.Laboratory and clinical aspects of human herpesvirus 6 infections.Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole genomic sequencing directly from clinical specimens.Automated Nucleic Acid Extraction Systems for Detecting Cytomegalovirus and Epstein-Barr Virus Using Real-Time PCR: A Comparison Study Between the QIAsymphony RGQ and QIAcube Systems.Quantitative nucleic acid amplification methods and their implications in clinical virology.Quantification of cytomegalovirus viral load.Treatment of cytomegalovirus infections beyond acute disease to improve human health.Diarrhea caused by viruses in transplant recipients.Emerging cytomegalovirus management strategies after solid organ transplantation: challenges and opportunities.The Human Virome - Implications for Clinical Practice in Transplantation Medicine.Expanding role of cytomegalovirus as a human pathogen.Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients.Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and Management.Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.High human cytomegalovirus DNAemia early post-transplantation associates with irreversible and progressive loss of renal function - a retrospective study.Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients.Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients.Comparative Performance of Reagents and Platforms for Quantitation of Cytomegalovirus DNA by Digital PCR.Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples.When polymerase chain reaction does not help: cytomegalovirus pneumonitis associated with very low or undetectable viral load in both blood and bronchoalveolar lavage samples after lung transplantation.Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.Clinical relevance of the plasma load of cytomegalovirus in patients infected with HIV--a survival analysis.Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.Diagnosis and monitoring of cytomegalovirus infection by the quantification of viral load in dried blood spots samples.Cytomegalovirus Infection under a Hybrid Strategy in Pediatric Liver Transplantation: A Single-Center Experience.Cytomegalovirus Infection after Renal Transplantation: Occurrence, Clinical Features, and the Cutoff for Antigenemia in a University Hospital in Brazil.A Markov Analysis of Screening for Late-Onset Cytomegalovirus Disease in Cytomegalovirus High-Risk Kidney Transplant Recipients.The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care.Acute liver dysfunction not resulting from hepatitis virus in immunocompetent children.The Potential Harm of Cytomegalovirus Infection in Immunocompetent Critically Ill Children.Acute Gastrointestinal Bleeding Due to Cytomegalovirus Colitis in a Patient with Common Variable Immunodeficiency.High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation
P2860
Q27755387-B9D2591D-5E6D-4F98-A1E0-86C67048FBDEQ33897739-0F7577AD-F37D-486C-AC21-C3601AF728BBQ33912913-3B59A91E-CB1B-4559-98D4-BB75B3AF8447Q35482603-AD1281D4-4934-4B1C-953A-A3ADB8818A60Q35571656-BA78D124-B320-41DF-90CB-456BCE4016A0Q36331587-1CA22536-9BB9-48F9-8C04-F47D6B1EE870Q37547775-3F7C11FE-CDB7-45ED-A482-C5FB9CF9FCACQ37668438-E51E825E-794E-4FFA-B473-E25A90328338Q38171537-BF702C94-0BE5-4161-9F59-3B425FC7BFE4Q38176940-FA1A5B5D-158E-4223-ADC6-D4528FF92AB5Q38205920-BFD24121-221D-4531-9990-9544BDB9B3BCQ38225475-FB8821A2-159A-466E-A189-09DEB287B622Q38654977-597F462E-C0B2-4FCF-9A26-9C2F490EBE99Q38673038-CC2BB055-6CFD-4D42-A0B3-9A86E704D212Q39281206-BC1B631E-4DDC-4EE2-874B-0B0A0731AA97Q39296120-F5CABECC-E610-41B1-A240-9E16E1064FA4Q39405795-D7AB989C-1D6D-42A7-A119-E61C8F569617Q40120411-965660BA-D30A-41B3-8651-698C9049641CQ40232106-5E456F33-C8CB-4AE0-B9F0-4AC0E384B967Q40243669-623BE63B-7C33-4103-A2E7-34BB4BF1455FQ40353704-9017AE67-AC73-47F7-A2DB-54DE9CBC92FFQ40398451-CEC2C6DB-C798-4E33-B03E-F007E8E69677Q40425776-531604DD-2CAF-44D7-B2E4-9E5025C7117BQ40645930-A9705382-3FBB-4472-A61D-F47393F5F7B1Q40698934-57063E3E-EDF6-438C-9339-6504549F1B98Q40779427-65E404AC-6CB7-47B7-9E5C-2D934B72C18EQ40901843-0A3A91B7-C352-41CF-81FE-BE04D3C33FA4Q41342348-9D36F577-F2CE-40BD-8EB7-88C2BA2C3FB8Q42202214-139A95F0-1CEE-4213-A208-A6FD4359E795Q42214155-48324361-3320-4CB7-B2BF-FAA13F04C505Q42230348-ECB116FC-0E16-4A72-9580-399A335CD1B7Q42261599-0B77EFEB-D7EA-40ED-B82E-B8684931723AQ47180545-93ECC5C2-CCC0-4E6E-A30D-3B033FE896A4Q48633112-E4795D14-A50F-478F-8244-C0CF5BED811DQ53108123-754CB83B-D72E-44C5-A363-A3BBB92E2202Q54130042-E7041580-8F9F-45D1-A9B0-A59AB9260253Q55261466-7E3CA096-894C-444A-9638-951D50651A6CQ55285549-AE74E7D0-9C2E-4D9D-98D1-D41174B48136Q56963171-B3ADF50C-2F22-412A-9DE6-8CC4704A7383
P2860
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical utility of viral load ...... er solid organ transplantation
@ast
Clinical utility of viral load ...... er solid organ transplantation
@en
Clinical utility of viral load ...... er solid organ transplantation
@nl
type
label
Clinical utility of viral load ...... er solid organ transplantation
@ast
Clinical utility of viral load ...... er solid organ transplantation
@en
Clinical utility of viral load ...... er solid organ transplantation
@nl
prefLabel
Clinical utility of viral load ...... er solid organ transplantation
@ast
Clinical utility of viral load ...... er solid organ transplantation
@en
Clinical utility of viral load ...... er solid organ transplantation
@nl
P2860
P921
P356
P1476
Clinical utility of viral load ...... er solid organ transplantation
@en
P2093
R. R. Razonable
R. T. Hayden
P2860
P304
P356
10.1128/CMR.00015-13
P407
P577
2013-10-01T00:00:00Z